Download Files:

IBI-334

SKU T9901A-802-1 mg Category Brand:

This product is currently out of stock and unavailable.

Request Pricing

Products Details

Product Description

– IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.

Web ID

– T9901A-802

Storage Temperature

– -20℃

Shipping

– Blue Ice

Pathway

– JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Angiogenesis

Product type

– Inhibitory Antibodies

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

Related Products

Read more
Placeholder
Anti-MERS-2E6 mAb
Read more
Placeholder
Anti-MERS-3A1 mAb
Select options
Placeholder
Trastuzumab emtansine Price range: 2,112 CAD through 3,440 CAD
10 mg5 mg

1000 in stock

Read more
Placeholder
Labetuzumab govitecan
Select options
Placeholder
Reslizumab Price range: 1,059 CAD through 7,648 CAD
1 mg10 mg5 mg

1000 in stock

My Cart
Wishlist
Recently Viewed
Categories

Request Data Sheet / Safty Data Sheet

Please enable JavaScript in your browser to complete this form.
=

Price Request

Please enable JavaScript in your browser to complete this form.
=

Compare Products (0 Products)
document.addEventListener('elementor/popup/show', function() { if (typeof turnstile !== 'undefined') { document.querySelectorAll('.cf-turnstile').forEach(function(el) { if (!el.dataset.rendered) { turnstile.render(el); el.dataset.rendered = true; } }); } });